Cost and operational context for national human papillomavirus (HPV) vaccine delivery in six low- and middle-income countries
CONCLUSION: HPV vaccine delivery costs were lower than at introduction in some study countries. There were differences in the activities carried out for HPV vaccine delivery and the number of doses delivered, impacting the cost estimates.PMID:37949752 | DOI:10.1016/j.vaccine.2023.11.008
Source: Vaccine - Category: Allergy & Immunology Authors: Mercy Mvundura Rose Slavkovsky Fr édéric Debellut Teddy Naddumba Amare Bayeh Cathy Ndiaye Jacqueline Anena Elisabeth Vodicka Abdou Diop Deepa Gamage Clarisse Musanabaganwa Ganesh Tatkan Alfred Driwale Meseret Zelalem Ousseynou Badiane Samitha Ginige Ert Source Type: research
More News: Allergy & Immunology | Cervical Cancer Vaccine | Ethiopia Health | Genital Warts | Guyana Health | Human Papillomavirus (HPV) | Rwanda Health | Schools | Senegal Health | Sri Lanka Health | Study | Uganda Health | USA Health | Vaccines